119 related articles for article (PubMed ID: 15320959)
1. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.
Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ
J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959
[TBL] [Abstract][Full Text] [Related]
2. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
[TBL] [Abstract][Full Text] [Related]
3. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.
Ji X; Cheung R; Cooper S; Li Q; Greenberg HB; He XS
Hepatology; 2003 Mar; 37(3):610-21. PubMed ID: 12601359
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
[TBL] [Abstract][Full Text] [Related]
7. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
[TBL] [Abstract][Full Text] [Related]
8. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
[TBL] [Abstract][Full Text] [Related]
9. [An experimental study on antiviral effects of IFN alpha].
Lu NF; Huang AL; Tang N; Zheng RQ; Lin H; Zhu YB; Wu Y; Tao P
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):892-6. PubMed ID: 16381632
[TBL] [Abstract][Full Text] [Related]
10. Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro.
Taylor MW; Grosse WM; Schaley JE; Sanda C; Wu X; Chien SC; Smith F; Wu TG; Stephens M; Ferris MW; McClintick JN; Jerome RE; Edenberg HJ
J Interferon Cytokine Res; 2004 Feb; 24(2):107-18. PubMed ID: 14980075
[TBL] [Abstract][Full Text] [Related]
11. Pegylation of IFN-alpha and antiviral activity.
Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T; Blatt LM; Seiwert SD
J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
[TBL] [Abstract][Full Text] [Related]
13. Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Yano H; Basaki Y; Oie S; Ogasawara S; Momosaki S; Akiba J; Nishida N; Kojiro S; Ishizaki H; Moriya F; Kuratomi K; Fukahori S; Kuwano M; Kojiro M
J Interferon Cytokine Res; 2007 Mar; 27(3):231-8. PubMed ID: 17348822
[TBL] [Abstract][Full Text] [Related]
14. Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial.
De Leede LG; Humphries JE; Bechet AC; Van Hoogdalem EJ; Verrijk R; Spencer DG
J Interferon Cytokine Res; 2008 Feb; 28(2):113-22. PubMed ID: 18279106
[TBL] [Abstract][Full Text] [Related]
15. Impaired antiviral response in human hepatoma cells.
Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
[TBL] [Abstract][Full Text] [Related]
16. Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells.
Freeman J; Baglino S; Friborg J; Kraft Z; Gray T; Hill M; McPhee F; Hillson J; Lopez-Talavera JC; Wind-Rotolo M
J Viral Hepat; 2014 Jun; 21(6):e1-9. PubMed ID: 24827902
[TBL] [Abstract][Full Text] [Related]
17. Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.
El-Zayadi AR; Attia M; Barakat EM; Badran HM; Hamdy H; El-Tawil A; El-Nakeeb A; Selim O; Saied A
Am J Gastroenterol; 2005 Nov; 100(11):2447-52. PubMed ID: 16279899
[TBL] [Abstract][Full Text] [Related]
18. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
Ramon J; Saez V; Baez R; Aldana R; Hardy E
Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
[TBL] [Abstract][Full Text] [Related]
19. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
